Katrin A. Salva

Phase II Investigator-Initiated Study of Brentuximab Vedotin in Mycosis Fungoides and Sézary Syndrome With Variable CD30 Expression Level: A Multi-Institution Collaborative Project

Youn H. Kim, Mahkam Tavallaee, Uma Sundram et al. · Journal of Clinical Oncology · 2015 · 281 citations · Full text

Medicine, Hematology, Oncology +17

The <scp>PARACELSUS</scp> score: a novel diagnostic tool for pyoderma gangrenosum

Finja Jockenhöfer, Uwe Wollina, Katrin A. Salva et al. · British Journal of Dermatology · 2018 · 205 citations

Medicine, Clinical Sciences, Dermatology +13

Characterization of the peripheral neuropathy associated with brentuximab vedotin treatment of Mycosis Fungoides and Sézary Syndrome

Zachary Corbin, Annie Nguyen-Lin, Shufeng Li et al. · Journal of Neuro-Oncology · 2017 · 38 citations

Medicine, Neurology, Oncology +9

Brentuximab Vedotin Demonstrates Significant Clinical Activity in Relapsed or Refractory Mycosis Fungoides with Variable CD30 Expression

Michael Krathen, Uma Sundram, Sameer Bashey et al. · Blood · 2012 · 24 citations

Life Sciences, Immunology, Oncology +5

c-CBL E3 Ubiquitin Ligase Is Overexpressed in Cutaneous T-Cell Lymphoma: Its Inhibition Promotes Activation-Induced Cell Death

Jianqiang Wu, Katrin A. Salva, Gary S. Wood · Journal of Investigative Dermatology · 2014 · 20 citations · Full text

Life Sciences, Cell Biology, Oncology +15